Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs LillyDirect Foundayo
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · LillyDirect Foundayo: Check date not recorded
vs
Verdict58/ 100
Grade C · #398LillyDirect Foundayo
Eli Lilly's direct-pay pharmacy channel for Foundayo, a once-daily oral GLP-1 medicine with dose-dependent self-pay prices.
Visit LillyDirect FoundayoThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 58/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. LillyDirect Foundayo still earns its place — patients with a Foundayo prescription comparing Lilly's self-pay and commercial-insurance savings options.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results64
92
Real-world results64
97Price honesty20
97
Price honesty20
96Prescriber access92
96
Prescriber access92
88Formulary choice54
88
Formulary choice54
95Cancellation fairness56
95
Cancellation fairness56
93Member support65
93
Member support65
Price, coverage & features
| Metric | CoreAge Rx | LillyDirect Foundayo |
|---|---|---|
| Verdict Score | 94/100 | 58/100 |
| Grade | A | C |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
LillyDirect Foundayo
What we like
- Eligible commercially insured patients with coverage may pay $25/mo through Lilly's savings program
- Direct manufacturer channel — no compounded medication
- Daily oral pill that may be taken with or without food
- Self-pay and commercial-insurance savings options
The caveats
- Self-pay prices depend on dose and, at the highest doses, timely refills; introductory-dose discounts can expire
- Requires a prescription from a separate prescriber
- $25 commercial savings card excludes government beneficiaries; Medicare Bridge is a separate program
- Boxed warning and other label precautions require a discussion with your prescriber
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients with a Foundayo prescription comparing Lilly's self-pay and commercial-insurance savings options.
Visit LillyDirect Foundayo Read the full LillyDirect Foundayo review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for LillyDirect Foundayo does the reverse.
More on CoreAge Rx
More on LillyDirect Foundayo
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.